Innovative Food CEO granted 150K shares

IVFH’s chief executive officer received 150,000 shares of common stock as an equity grant under an amended and restated employment agreement.

Rhea-AI Filing Summary

INNOVATIVE FOOD HOLDINGS INC (symbol: IVFH) is the issuer of record for a Form 4 filing submitted to the SEC. Liarakos Argie reported acquisition or exercise transactions in this Form 4 filing.

INNOVATIVE FOOD HOLDINGS INC (IVFH) reported that Chief Executive Officer Argie Liarakos received a grant of 150,000 shares of Common Stock on September 14, 2026. The shares were issued at $0.00 per share pursuant to an amended and restated employment agreement dated September 12, 2026.

Following this equity award, Argie Liarakos directly holds 183,334 shares of IVFH common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 150,000 shares

Grant/Award 1 txn

Insider Liarakos Argie

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	150,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 183,334 shares (Direct)

Footnotes (1)

1. F1. The shares were issued to the Reporting Person pursuant to an amended and restated employment agreement entered into by and between the Issuer and the Reporting Person, dated September 12, 2026.

Key Figures

Shares granted: 150,000 shares Grant price per share: $0.00 per share Shares held after transaction: 183,334 shares +1 more

4 metrics

Shares granted 150,000 shares Common Stock granted to CEO on September 14, 2026

Grant price per share $0.00 per share Reported grant price for the 150,000-share award

Shares held after transaction 183,334 shares CEO’s direct holdings of IVFH Common Stock after the grant

Employment agreement date September 12, 2026 Date of amended and restated employment agreement underlying the share issuance

Key Terms

amended and restated employment agreement, Reporting Person, Common Stock

3 terms

amended and restated employment agreement regulatory

"The shares were issued to the Reporting Person pursuant to an amended and restated employment agreement"

Reporting Person regulatory

"The shares were issued to the Reporting Person pursuant to an amended and restated employment agreement"

Common Stock financial

"The shares were issued to the Reporting Person pursuant to an amended and restated employment agreement"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IVFH report for its CEO on this Form 4?

IVFH reported that Chief Executive Officer Argie Liarakos received a grant of 150,000 shares of Common Stock on September 14, 2026, classified as a grant, award, or other acquisition of non-derivative equity.

How many IVFH (IVFH) shares did the CEO receive and at what price?

The CEO received 150,000 shares of IVFH Common Stock at a reported price of $0.00 per share. The filing notes this as a grant or award rather than a market purchase.

What is the CEO’s total IVFH shareholding after this reported grant?

After the reported grant, Chief Executive Officer Argie Liarakos directly holds 183,334 shares of IVFH Common Stock, as shown in the post-transaction holdings column on the Form 4.

Why were the 150,000 IVFH shares issued to the CEO?

The 150,000 shares were issued to the CEO pursuant to an amended and restated employment agreement between IVFH and the reporting person, dated September 12, 2026, according to the footnote disclosure.

Was the IVFH CEO’s Form 4 transaction made under a Rule 10b5-1 plan?

No. The Form 4 indicates the document-level Rule 10b5-1 checkbox is not selected, and there is no footnote stating that the grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 06:03 AM Accepted by SEC EDGAR 09/17/2026 - 06:02 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liarakos Argie

(Last) (First) (Middle)

C/O INNOVATIVE FOOD HOLDINGS, INC.

2528 S 27TH AVE

(Street)

BROADVIEW ILLINOIS 60155

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INNOVATIVE FOOD HOLDINGS INC [ IVFH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		A		150,000(1)	A	$0	183,334	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were issued to the Reporting Person pursuant to an amended and restated employment agreement entered into by and between the Issuer and the Reporting Person, dated September 12, 2026.

	/s/ Argie Liarakos	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)